What factors would you consider when deciding between tamoxifen vs OFS/AI in premenopausal women with early stage HR+ breast cancer?

Answer from: Medical Oncologist at Academic Institution

I think the question is asking when would I recommend tamoxifen alone versus aromatase inhibitor plus medical ovarian suppression with agents like goserelin or leuprolide in a premenopausal breast cancer patient. There are multiple factors to consider. If she has a history of active endometriosis or...

Comments

Medical Oncologist at Advocate Aurora Health
The question was worded in a strange and confusing...

Medical Oncologist at Southwest Medcl Consult SC
Extremely useful ! Details much appreciated. ...

Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
The case "42-year-old premenopausal, high-risk lev...

Answer from: Medical Oncologist at Community Practice

Agree with above!

Comments

Medical Oncologist at NYU Winthrop Hospital
Great Review Dr. Soliman. Thanks

Please select the option that best describes you:

What factors would you consider when deciding between tamoxifen vs OFS/AI in premenopausal women with early stage HR+ breast cancer?

Related Questions